CU Anschutz Newsroom

Five years after the start of the COVID 19 pandemic, many people still say they feel more anxious, emotionally exhausted or socially disconnected than they did before 2020. Researchers at the University of Colorado Anschutz say these lingering effects may be tied to prolonged pandemic stress, a form of chronic uncontrollable stress that can reshape both brain and immune system function over time.

cognitive-psychologyneuroimagingneurosciencepsychology

Welcome to Science Snapshot , a quick digest of the latest research happening across the CU Anschutz campus. Hear from researchers as they briefly explain one of their recent studies and how it could improve healthcare. This installment explores the effects of acid reflux medications on the gut microbiome and whether standard use of component blood tranfusions in trauma settings is better than us…

biologymedicinemicrobiologypharmacology

The Takeaway: A CU Anschutz-led study suggests acetaminophen may relieve pain by interacting with the body’s endocannabinoid system, which regulates pain and inflammation. In knee replacement patients, changes in cannabis-like molecules were linked to both acetaminophen use and reported pain levels. These findings could inform more targeted pain therapies in the future. Despite acetaminophen’s po…

medicinepain-reliefpharmacology
matthew.hastings@ucdenver.edu (Matthew Hastings)
6d ago

The takeaway: A group of four faculty presenters detail the work behind their startups at a Fast Pitch event for a $10,000 award: mindLAMP Care, Retro Nephrix, NeuroVesica, Parley Neurotech. The CU Anschutz Innovations event provides a window into how ideas move from the lab to improving health for patients. How would you convince a room of strangers you had the next great idea in healthcare in u…

The takeaway: Orforglipron is an FDA-approved non-peptide oral GLP-1 pill, offering a potential alternative to injectable weight-loss drugs. Demand for GLP-1 medications has surged in recent years, but cost and injectable delivery have limited access for many patients. A CU Anschutz researcher is overseeing a clinical trial for orforglipron, and a patient shares her experience in the trial. Every…

clinical-trialsmedicinepharmacology
debra.melani@cuanschutz.edu (Debra Melani)
10d ago

Thomas Delong , PhD, moved to Colorado from Germany two decades ago intent on one thing: understanding the origin of type 1 diabetes (T1D) and finding ways to stop it. Diagnosed at age 12 with the disease that affects 9.5 million people worldwide, Delong’s mission was deep-rooted and personal.

diabetesendocrinologymedicinepublic-health

For 14 years, Grace Hamilton lived with an undiagnosed disease that left her feeling frustrated and alone. Misunderstanding from other kids marked her youth, along with subtle disappointment from her parents, who had no idea that her climbing weight and fluctuating emotions were largely disease driven.

endocrinologymedicinepublic-healthreproductive-health
kelsea.pieters@cuanschutz.edu (Kelsea Pieters)
13d ago

Polycystic ovary syndrome (PCOS), a condition affecting more than 170 million people worldwide, has been officially renamed Polyendocrine Metabolic Ovarian Syndrome (PMOS) following a landmark global consensus study published today in The Lancet .

infectious-diseasemedicinepublic-health
matthew.hastings@ucdenver.edu (Matthew Hastings)
20d ago

Jeffrey Stansbury , PhD, senior associate dean for research and professor at the CU Anschutz School of Dental Medicine , has four properties he wants the next generation of dentures to contain : Cheaper, faster to make, more durable and potentially able to combat bacteria and fungus.

3d-printingbiomedical-engineeringengineering
debra.melani@cuanschutz.edu (Debra Melani)
21d ago

Just as every human body starts with one cell, every healthcare advancement begins with basic science. No matter how amazing the end result is, scientific success stories generally originate with a single idea in a single lab and take decades of persistent teamwork to become something of note – if they ever even do.

medicinepharmacology

“Safety first” is the message a CU Anschutz behavioral neurologist wants caregivers of older adults with memory disorders and dementia to keep in mind. The recommendation is based on a behavior that’s been noticed more frequently in patients with many brain diseases – hoarding.

behavioral-scienceclinical-neuroscienceneurosciencepsychology

When we eat sugary and starchy foods, the bacteria in our mouth feed on the small bits of food left on our teeth. While digesting the bits of food left behind, bacteria produce acids. These acids slowly wear down the tooth enamel, leading to cavities and tooth decay if not cleaned away.

dentistrymedicinepublic-health

Welcome to Science Snapshot, a quick digest of the latest research happening across the CU Anschutz campus. Hear from researchers as they briefly explain one of their recent studies and how it could improve healthcare. In this installment, we highlight the influence mothers' screen-related behaviors have on toddlers' screen use and how lactation consultants need more education to confidently coun…

developmental-psychologymedicinepsychologypublic-health
Christopher.Casey@ucdenver.edu (Chris Casey)
28d ago

A groundbreaking and fast-paced effort – combining biologic, clinical and regulatory expertise at the University of Colorado Anschutz – has helped propel an ambitious nationwide attempt to reverse osteoarthritis (OA), a painful degenerative disease that affects 32 million Americans.

infectious-diseasemedicinepublic-health
debra.melani@cuanschutz.edu (Debra Melani)
4/21/2026

Knowing that women are diagnosed with multiple sclerosis (MS) at three times the rate of men, particularly during their 30s and 40s, scientists in the CU Anschutz lab of Kimberley Bruce , PhD, recently took that window of opportunity and ran with it.

autoimmune-diseasesmedicineneurology

Researchers at the Colorado School of Public Health (CSPH) are studying how cannabis use affects driving performance. Using a “video game-like” simulator, they measure how people drive before and after consuming cannabis.

behavioral-sciencemedicinepublic-health
research.ioresearch.io

Sign up to keep scrolling

Create your feed subscriptions, save articles, keep scrolling.

Already have an account?